Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches.
Corrigendum.
ADC evaluation of the corticospinal tract in multiple sclerosis.
The Encephalitogenic, Human Myelin Oligodendrocyte Glycoprotein-Induced Antibody Repertoire Is Directed towards Multiple Epitopes in C57BL/6-Immunized Mice.
Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica.
New insights into an autoimmune mechanism, pharmacological treatment and relationship between multiple sclerosis and inflammatory bowel disease.
Immune response to chemically modified proteome.
Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients.
IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation.
The temporal dynamics of visual processing in multiple sclerosis.
Cerebrospinal Fluid IL-12p40, CXCL13 and IL-8 as a Combinatorial Biomarker of Active Intrathecal Inflammation.
Targeting cells in motion: migrating toward improved therapies.
Advanced magnetic resonance imaging in pediatric multiple sclerosis.
Duloxetine for the Treatment of Overactive Bladder Syndrome in Multiple Sclerosis: A Pilot Study.
Interactions and tradeoffs between cell recruitment, proliferation, and differentiation affect CNS regeneration.
Tetrahydrocannabinol for tremor in multiple sclerosis.
Structure-Kinetics Relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as CCR2 antagonists.
Childhood obesity is a risk factor for multiple sclerosis.
The role of Th17 cells in patients with relapsing-remitting multiple sclerosis: Interleukin-17A and interleukin-17F serum levels.
Activity-dependent regulation of excitable axonal domains.
Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study.
Nivolumab-induced chronic inflammatory demyelinating polyradiculoneuropathy mimicking rapid-onset Guillain-Barré syndrome: a case report.
Development of Experimental Autoimmune Encephalomyelitis Critically Depends on CD137 Ligand Signaling.
The mechanism of effective electroacupuncture on T cell response in rats with experimental autoimmune encephalomyelitis.
Impact on health-related quality of life in multiple sclerosis patients due to a managed care program in Colombia.
Pages
« first
‹ previous
…
400
401
402
403
404
405
406
407
408
…
next ›
last »